Motor Control Prevention Strategies in Basketball Players

December 4, 2024 updated by: Rocío Llamas-Ramos, University of Salamanca

Motor Control Prevention Strategies for Ankle Sprains in Basketball Players

Ankle sprains have always been considered as isolated injury entities, in which the passive ankle stabilisation system suffered an elongation due to trauma. Today, this concept of an isolated injury has evolved into a more holistic concept, interrelated with various components from different sources.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Basketball players aged between 10-18 years old who play regularly in one of the basketball clubs in the city of Salamanca.

Exclusion Criteria:

  • previous injuries
  • fractures
  • use of orthoses and technical aids

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motor control group

Basketball players aged between 10-18 years old who play regularly in one of the basketball sports clubs in the city of Salamanca.

The study will be carried out in 20 sessions. As for the proprioception and balance work, a simple proposal of exercises will be made, increasing the difficulty from the fifth session onwards. From the 10th session onwards, unstable surfaces will be introduced as long as our athletes are capable of achieving the task of less complexity. If it is not possible to progress in intensity, the same level will be maintained.

Propioceptive exercises
Active Comparator: Control

Basketball players aged between 10-18 years old who play regularly in one of the basketball sports clubs in the city of Salamanca.

These participants shall carry out their usual treatment

Usual exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: At the beginning and at 9 months
Measurements of the articular range of the ankle joint
At the beginning and at 9 months
Musculature Strength
Time Frame: At the beginning and at 9 months
Measurement of the strength of the musculature of the back of the leg by means of isokinetic tests
At the beginning and at 9 months
Presence of Myofascial trigger points
Time Frame: At the beginning and at 9 months
Diagnostic criteria established by Travell and Simons, the presence or absence of active or latent myofascial trigger points will be assessed.
At the beginning and at 9 months
Speed of contraction of the musculature
Time Frame: At the beginning and at 9 months
By means of the isokinetic tests and the aforementioned exploratory curves, the speed of contraction of the musculature of the back of the leg and foot will be evaluated
At the beginning and at 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 15, 2024

Primary Completion (Estimated)

March 31, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

July 9, 2024

First Submitted That Met QC Criteria

July 19, 2024

First Posted (Actual)

July 25, 2024

Study Record Updates

Last Update Posted (Estimated)

December 9, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MOTORCONTROL2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Motor Disorders

Clinical Trials on Experimental Group

Subscribe